Pregnancy: Triamcinolone should not be used in the first 5 months of pregnancy, as animal trials have indicated teratogenic effects and no findings are available with regard to the safety of human use during this period. In long-term use, intrauterine growth impairment cannot be excluded. When treating at the end of pregnancy, there is a risk of adrenocortical atrophy for the foetus.
Breast-feeding: Glucocorticoids are excreted in human milk. Breast-feeding should be discontinued if treatment with higher doses or long-term treatment is required.
Fertility: No experience is available regarding the effects of Trispan on fertility.